KINLYTIC vs PRADAXA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. KINLYTIC and PRADAXA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KINLYTIC	PRADAXA
Rating	New	72/100
Pharmacy pays	—	~$27.04 /30
Type	RX	RX
Active ingredient	UROKINASE	DABIGATRAN ETEXILATE MESYLATE
Manufacturer	Microbix Biosystems	Boehringer Ingelheim
Dosage forms	Injectable	Capsule, Oral pellets
Drug class	—	Direct Thrombin Inhibitor
Boxed warning	None	Boxed warning
Treats	Coronary Thrombosis, Vascular Graft Occlusion, Myocardial Infarction	Pulmonary Embolism, Venous Thrombosis

kinlytic pradaxa

Rating

New

72/100

Pharmacy pays

—

~$27.04 /30

Type

Active ingredient

UROKINASE

DABIGATRAN ETEXILATE MESYLATE

Manufacturer

Microbix Biosystems

Boehringer Ingelheim

Dosage forms

Injectable

Capsule, Oral pellets

Drug class

—

Direct Thrombin Inhibitor

Boxed warning

None

Boxed warning

Treats

Coronary Thrombosis, Vascular Graft Occlusion, Myocardial Infarction

Pulmonary Embolism, Venous Thrombosis

Frequently asked questions

What is the difference between Kinlytic and Pradaxa?

Kinlytic contains Urokinase, while Pradaxa contains Dabigatran Etexilate Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.